The association between cagA+ H. pylori infection and distal gastric cancer: A proposed model

Digestive Diseases and Sciences

Volumn 49, Issue 7-8, 2004, Pages 1116-1122

  A Marhoon, Mohammed S ^a   Nun, Sheila ^b   Soames, Roger W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

cagA+; cagA ; cancer; gastric; H. pylori; model

Indexed keywords

CAGA PROTEIN; PROSTAGLANDIN E2;

ADULT; AGE; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; ERADICATION THERAPY; FEMALE; GENETIC ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HYDROPHOBICITY; MALE; MOLECULAR MODEL; OBSERVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCUS; THICKNESS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; COMORBIDITY; DINOPROSTONE; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROPHOBICITY; MALE; MODELS, BIOLOGICAL; STOMACH NEOPLASMS;

EID: 4444303069     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000037797.62164.4e     Document Type: Article

References (54)

1. Dixon MF: Helicobacter pylori and chronic gastritis. In Helicobacter pylori and Gastroduodenal Disease. BJ Rathbone, RV Heatley (eds). Oxford, Blackwell Scientific, 1992.
2. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science 284:1328-1333, 1999
3. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte, M: Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345:1591-1594, 1995
4. Forman D, Newell DG, Fullerton F, Yamell JW, Stacey AR, Wald N, Sitas, F: Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302:1302-1305, 1991
5. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture [Review]. Eur J Cancer 37(Suppl 8): S4-S66, 2001
6. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606, 1993
7. Powell J, McConkey CC: The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1:265-269, 1992
8. Kelly JR, Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1-9, 2003
9. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 64:31-49, 1965
10. International agency for research on cancer. Schistosomes, liver flukes and Helicobacter pylori: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1-241, 1994
11. Danesh J: Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 13:851-856, 1999
12. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y: Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640-643, 1991
13. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136, 1991
14. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S: Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 34:450-454, 1999
15. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M: Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20:669-676, 1999
16. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G: Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopie resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6:639-642, 1997
17. Schandl L, Malfertheiner P, Ebert MP: Prevention of gastric cancer by Helicobacter pylori eradication? Results from clinical intervention studies. Dig Dis 20:18-22, 2002
18. Covacci A, Rappuoli R: Helicobacter pylori: Molecular evolution of a bacterial quasi-species. Curr Opin Microbiol 1:96-102, 1998
19. Rudi J, KoIb C, Maiwald M, Zuna I, von Herbay A, Galle PR, Stremmel W: Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 42:1652-1659, 1997
20. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332-335, 1991
21. Blaser MJ: The interaction of cag+ Helicobacter pylori strains with their hosts. In Helicobacter pylori: Basic Mechanisms to Clinical Cure 1998. RH Hunt, GNJ Tytgat (eds). Dordrecht, Kluwer Academic, 1998
22. Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in chronic active gastritis. Lancet 1:1273-1275, 1983
23. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 89:S116-S128, 1994
24. Goodwin S: Detection of H. pylori by biopsy urease, histology, and culture. In Helicobacter pylori Protocols. CL Clayton, HL Mobley (eds). Totowa, NJ, Human Press, 1997
25. Collins CH, Lyne PM: Counting micro-organisms. In Microbiological Methods. CH Collins, PM Lyne (eds). London, Boston, Butterworths, 1984
26. Jordan N, Newton J, Pearson J, Allen A: A novel method for the visualization of the in situ mucus layer in rat and man. Clin Sci 95:97-106, 1998
27. Spychal RT, Marrero JM, Saverymuttu SH, Northfield TC: Measurement of the surface hydrophobicity of human gastrointestinal mucosa. Gastroenterology 97:104-111, 1989
28. Ahmed A, Holton J, Vaira D, Smith SK, Hoult JR: Eicosanoid synthesis and Helicobacter pylori associated gastritis: increase in leukotriene C4 generation associated with H. pylori colonization. Prostaglandins 44:75-86, 1992
29. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M: A model for gastric cancer epidemiology. Lancet 2:58-60, 1975
30. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735-6740, 1992
31. Testerman TL, McGee DJ, Mobley HL: Adherence and colonization. In Helicobacter pylori: Physiology and Genetics. HL Mobley, GL Mendz, SL Hazell (eds). Washington DC, ASM Press, 2001
32. Cryer B: Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum. Gastroenterol Clin North Am 30:877-894, 2001
33. Chan FK, To KF, Ng YP, Lee TL, Cheng AS, Leung WK, Sung JJ: Expression and cellular localization of COX-1 and -2 in Helicobacter pylori gastritis. Aliment Pharmacol Ther 15:187-193, 2001
34. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM: Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 94:1218-1223, 1999
35. Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA: Role of surface active phospholipids in gastric cytoprotection. Science 219:1327-1329, 1983
36. Kerss S, Allen A, Garner A: A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. Clin Sci 63:187-195, 1982
37. Asaka M, Sepulveda AR, Sugiyama T, Graham DY: Gastric Cancer. In Helicobacter pylori: Physiology and Genetics. HL Mobley, GL Mendz, SL Hazell (eds). Washington DC, ASM Press, 2001
38. Grisham MB: Review article: chronic inflammation and reactive oxygen and nitrogen metabolism - Implications in DNA damage and mutagenesis. Aliment Pharmacol Ther Supplement 14:3-9, 2000
39. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M: Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: A potential pathway to cancer? Helicobacter 8:227-234, 2003
40. Rokkas T, Ladas S, Liatsos C, Petridou E, Papatheodorou G, Theocharis S, Karameris A, Raptis S: Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig Dis Sci 44:487-493, 1999
41. Shibayama K, Kamachi K, Yagi T, Yamane K, Doi Y, Shibata N, Kato H, and Arakawa Y: A novel apoptosis-inducing protein from Helicobacter pylori. Helicobacter 8(4):354, 2003
42. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, Wang TC: Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 63:942-950, 2003
43. Mitchell HM: Epidemiology of Infection. In Helicobacter pylori: Physiology and Genetics. HL Mobley, GL Mendz, SL Hazell (eds). Washington DC, ASM Press, 2001
44. Day DW, Dixon MF: Acute and Chronic Gastritis. In Biopsy Pathology of the Oesophagus, Stomach and Duodenum. DW Day, MF Dixon (eds). Hong Kong, Chapman & Hall Medical, 1995
45. Sugiyama A, Ikeno T, Ishida K, Maruta F, Murakami M, Sato T, Saito H, Ishizone S, Kawasaki S, Ota H, Katsuyama T: Paradoxical role of Helicobacter pylori infection: protective effect against ethanol-induced gastric mucosal injury in Mongolian gerbils. Dig Dis Sci 46:2433-2439, 2001
46. Sarosiek I, Marshall BJ, Peura DA, Hoffman S, Feng T, McCallum RW: Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am J Gastroenterol 86:729-734, 1991
47. Newton JL, Jordan N, Oliver L, Strugala V, Pearson J, James OF, Allen A: Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut 43:470-475, 1998
48. Goggin PM, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC: Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. Gastroenterology 103:1486-1490, 1992
49. Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu, CW, Corbishley CM, Maxwell JD, Northfield TC: Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection. Gastroenterology 98:1250-1254, 1990
50. Day AS, Jones NL, Policova Z, Jennings HA, Yau EK, Shannon P, Neumann AW, Sherman PM: Characterization of virulence factors of mouse-adapted Helicobacter pylori strain SS1 and effects on gastric hydrophobicity. Dig Dis Sci 46:1943-1951, 2001
51. Oderda G, D'Alessandro M, Mariani P, Lionetti P, Bonamico M, Dell'Olio D, Ansaldi N: Prostaglandin E2 in gastric mucosa of children with Helicobacter pylori gastritis: relation to thickness of mucus gel layer. J Clin Pathol 46:836-839, 1993
52. Avunduk C, Suliman M, Gang D, Polakowski N, Eastwood GL: Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate. Dig Dis Sci 36:431-434, 1991
53. Goren A: Campylobacter pylori and acid secretion. Lancet 2:212, 1989
54. Taha AS, Boothman P, Holland P, McKinlay A, Upadhyay R, Kelly RW, Lee F, Russell RI: Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol 85:47-50, 1990